Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,515 | -21,568 | -13,128 | -29,723 | -97,041 |
| Depreciation Amortization | 79 | 49 | 22 | 35 | 2,563 |
| Accounts receivable | -589 | -178 | -125 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,210 | -442 | 189 | N/A | 898 |
| Other Working Capital | -1,289 | -2,866 | 2,148 | -334 | 1,578 |
| Other Operating Activity | 8,823 | 6,844 | 5,635 | 9,825 | 19,719 |
| Operating Cash Flow | $-22,701 | $-18,161 | $-5,259 | $-20,197 | $-72,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -225 | -186 | -171 | -279 | -363 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -127,212 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 120,720 |
| Other Investing Activity | -1,485 | -942 | -877 | 8,212 | 0 |
| Investing Cash Flow | $-1,710 | $-1,128 | $-1,048 | $7,933 | $-6,855 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,338 | 7,338 | 7,338 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -142 |
| Common Stock Issued | 61 | 57 | 9 | N/A | 84,505 |
| Other Financing Activity | 26,972 | 27,991 | 27,961 | 9,755 | 0 |
| Financing Cash Flow | $34,371 | $35,386 | $35,308 | $9,755 | $84,363 |
| Exchange Rate Effect | N/A | N/A | N/A | 3,921 | N/A |
| Beginning Cash Position | 8,371 | 8,371 | 8,371 | 10,880 | 24,340 |
| End Cash Position | 18,331 | 24,468 | 37,372 | 8,371 | 29,565 |
| Net Cash Flow | $9,960 | $16,097 | $29,001 | $-2,509 | $5,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,701 | -18,161 | -5,259 | -20,197 | -72,283 |
| Capital Expenditure | -225 | -186 | -171 | N/A | -400 |
| Free Cash Flow | -22,926 | -18,347 | -5,430 | -20,197 | -72,683 |